💰Notice of Interest Rate on Overdue Debts - HHS Regulations
This notice from the Department of Health and Human Services details the annual interest rates applied to overdue debts in health programs. The interest rates are determined by the Secretary of the Treasury and published quarterly, impacting the financial obligations of affected entities.
Learn More🩺Notice of Meeting for Office of AIDS Research Advisory Council
The Department of Health and Human Services announces a virtual meeting for the Office of AIDS Research Advisory Council. The meeting will cover strategic developments and priorities in HIV research, inviting public participation and comments on the agenda. Access details and contact information for inquiries are provided.
Learn More🏥Proposed Info Collection for Foster Care & Adoption Assistance
The Administration for Children and Families (ACF) is requesting a 3-year extension and revisions to the Plan for Foster Care and Adoption Assistance--Title IV-E, (OMB#: 0970-0433, expiration July 31, 2025). This plan also incorporates the plan requirements for the optional guardianship assistance, Title IV-E prevention services and the Title IV-E kinship navigator programs.
Learn More🧑🔬NIH Closed Meetings for Grant Evaluations
The Department of Health and Human Services announces closed meetings by the National Institutes of Health, focusing on the review of grant applications within various scientific committees. These discussions are geared toward evaluating innovative research proposals, critical for advancing health and scientific initiatives.
Learn More💉Correction Notice for Exclusive Patent License on Drug Delivery System
The Department of Health and Human Services corrected a previous notice regarding a prospective grant of an exclusive patent license for a macromolecular drug delivery platform. This announcement pertains specifically to its size-dependent brain and lymphatic distribution characteristics, aiming to facilitate drug delivery innovation.
Learn More💊FDA Notice on Pharmaceutical Supply Chain Compliance Requirements
The Food and Drug Administration (FDA, the Agency, or we) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995 (PRA).
Learn More💊FDA Comment Request on Tropical Disease Priority Review Vouchers
The Food and Drug Administration (FDA or Agency) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on Tropical Disease Priority Review Vouchers.
Learn More📄FDA Notice on Financial Disclosure for Clinical Investigators
The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.
Learn More🧪FDA Notice on Reagents for Detection of Specific Novel Influenza A Viruses
The Food and Drug Administration (FDA or Agency) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on the information collection associated with Agency guidance on reagents for detection of specific novel influenza A viruses.
Learn More🏥Notice of NIH Clinical Center Research Hospital Board Meeting
This notice announces a hybrid meeting of the NIH Clinical Center Research Hospital Board, detailing the agenda, date, and contact information for interested participants. It highlights opportunities for public comment and emphasizes the necessity for special assistance requests, ensuring accessibility for all attendees. The meeting will focus on leadership updates and other business matters relevant to health research.
Learn More